Trademark Overview
On Wednesday, August 27, 2025, a trademark application was filed for SEED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SEED THERAPEUTICS trademark a serial number of 99361623. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, April 24, 2026. This trademark is owned by SEED Therapeutics US, Inc.. The SEED THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Drug discovery, pharmaceutical drug development, and drug validation services; Pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical research and medical research information about pharmaceutical drug development via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology research, and design, planning, and implementation of clinical trials; research and development of new products; scientific, research and development services; medical research services; Providing information about medical and scientific research relating to the identification of ubiquitin ligases for the purposes of degrading a disease-causing protein; scientific consultancy services in the field of identifying ubiquitin ligases for the purposes of degrading a disease-c...
